B-Cell Maturation Antigen (BCMA) Targeted Therapies
B-Cell Maturation Antigen (BCMA) Targeted Therapies market is segmented by region (country), play ... Read More
1 Study Coverage 1.1 Antibody Humanization Revenue in Antibody Humanization Business (2017-2022) & (US$ Million) Introduction 1.2 Global Antibody Humanization Outlook 2017 VS 2022 VS 2028 1.2.1 Global Antibody Humanization Market Size for the Year 2017-2028 1.2.2 Global Antibody Humanization Market Size for the Year 2017-2028 1.3 Antibody Humanization Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Antibody Humanization in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Antibody Humanization Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Antibody Humanization Market Dynamics 1.4.1 Antibody Humanization Industry Trends 1.4.2 Antibody Humanization Market Drivers 1.4.3 Antibody Humanization Market Challenges 1.4.4 Antibody Humanization Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Antibody Humanization by Type 2.1 Antibody Humanization Market Segment by Type 2.1.1 Monoclonal Antibodies 2.1.2 Bispecific Antibodies 2.1.3 CDR Grafted Antibodies 2.2 Global Antibody Humanization Market Size by Type (2017, 2022 & 2028) 2.3 Global Antibody Humanization Market Size by Type (2017-2028) 2.4 United States Antibody Humanization Market Size by Type (2017, 2022 & 2028) 2.5 United States Antibody Humanization Market Size by Type (2017-2028) 3 Antibody Humanization by Application 3.1 Antibody Humanization Market Segment by Application 3.1.1 HIV 3.1.2 SARS 3.1.3 RSV 3.1.4 Prion 3.2 Global Antibody Humanization Market Size by Application (2017, 2022 & 2028) 3.3 Global Antibody Humanization Market Size by Application (2017-2028) 3.4 United States Antibody Humanization Market Size by Application (2017, 2022 & 2028) 3.5 United States Antibody Humanization Market Size by Application (2017-2028) 4 Global Antibody Humanization Competitor Landscape by Company 4.1 Global Antibody Humanization Market Size by Company 4.1.1 Top Global Antibody Humanization Companies Ranked by Revenue (2021) 4.1.2 Global Antibody Humanization Revenue by Player (2017-2022) 4.2 Global Antibody Humanization Concentration Ratio (CR) 4.2.1 Antibody Humanization Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Antibody Humanization in 2021 4.2.3 Global Antibody Humanization Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Antibody Humanization Headquarters, Revenue in Antibody Humanization Business (2017-2022) & (US$ Million) Type 4.3.1 Global Antibody Humanization Headquarters and Area Served 4.3.2 Global Antibody Humanization Companies Revenue in Antibody Humanization Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Antibody Humanization Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Antibody Humanization Market Size by Company 4.5.1 Top Antibody Humanization Players in United States, Ranked by Revenue (2021) 4.5.2 United States Antibody Humanization Revenue by Players (2020, 2021 & 2022) 5 Global Antibody Humanization Market Size by Region 5.1 Global Antibody Humanization Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Antibody Humanization Market Size by Region (2017-2028) 5.2.1 Global Antibody Humanization Market Size by Region: 2017-2022 5.2.2 Global Antibody Humanization Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Antibody Humanization Market Size YoY Growth 2017-2028 6.1.2 North America Antibody Humanization Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Antibody Humanization Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Antibody Humanization Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Antibody Humanization Market Size YoY Growth 2017-2028 6.3.2 Europe Antibody Humanization Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Antibody Humanization Market Size YoY Growth 2017-2028 6.4.2 Latin America Antibody Humanization Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Antibody Humanization Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Antibody Humanization Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Accurus Biosciences 7.1.1 Accurus Biosciences Company Details 7.1.2 Accurus Biosciences Business Overview 7.1.3 Accurus Biosciences Antibody Humanization Introduction 7.1.4 Accurus Biosciences Revenue in Antibody Humanization Business (2017-2022) 7.1.5 Accurus Biosciences Recent Development 7.2 IONTAS 7.2.1 IONTAS Company Details 7.2.2 IONTAS Business Overview 7.2.3 IONTAS Antibody Humanization Introduction 7.2.4 IONTAS Revenue in Antibody Humanization Business (2017-2022) 7.2.5 IONTAS Recent Development 7.3 Lonza 7.3.1 Lonza Company Details 7.3.2 Lonza Business Overview 7.3.3 Lonza Antibody Humanization Introduction 7.3.4 Lonza Revenue in Antibody Humanization Business (2017-2022) 7.3.5 Lonza Recent Development 7.4 Oak BioSciences 7.4.1 Oak BioSciences Company Details 7.4.2 Oak BioSciences Business Overview 7.4.3 Oak BioSciences Antibody Humanization Introduction 7.4.4 Oak BioSciences Revenue in Antibody Humanization Business (2017-2022) 7.4.5 Oak BioSciences Recent Development 7.5 Panorama Research 7.5.1 Panorama Research Company Details 7.5.2 Panorama Research Business Overview 7.5.3 Panorama Research Antibody Humanization Introduction 7.5.4 Panorama Research Revenue in Antibody Humanization Business (2017-2022) 7.5.5 Panorama Research Recent Development 7.6 PX'Therapeutics 7.6.1 PX'Therapeutics Company Details 7.6.2 PX'Therapeutics Business Overview 7.6.3 PX'Therapeutics Antibody Humanization Introduction 7.6.4 PX'Therapeutics Revenue in Antibody Humanization Business (2017-2022) 7.6.5 PX'Therapeutics Recent Development 7.7 Yurogen Biosystems 7.7.1 Yurogen Biosystems Company Details 7.7.2 Yurogen Biosystems Business Overview 7.7.3 Yurogen Biosystems Antibody Humanization Introduction 7.7.4 Yurogen Biosystems Revenue in Antibody Humanization Business (2017-2022) 7.7.5 Yurogen Biosystems Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer
List of Tables Table 1. Antibody Humanization Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Antibody Humanization Market Trends Table 3. Antibody Humanization Market Drivers Table 4. Antibody Humanization Market Challenges Table 5. Antibody Humanization Market Restraints Table 6. Global Antibody Humanization Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Antibody Humanization Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Antibody Humanization Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Antibody Humanization Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Antibody Humanization Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Antibody Humanization Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Antibody Humanization Revenue Share by Player, 2017-2022 Table 13. Global Antibody Humanization Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Antibody Humanization by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Humanization as of 2021) Table 15. Top Players of Antibody Humanization in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Antibody Humanization Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Antibody Humanization Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Antibody Humanization Players in United States Market, Ranking by Revenue (2021) Table 20. United States Antibody Humanization Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Antibody Humanization Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Antibody Humanization Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Antibody Humanization Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Antibody Humanization Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Antibody Humanization Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Antibody Humanization Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Antibody Humanization Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Antibody Humanization Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Antibody Humanization Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Accurus Biosciences Company Details Table 31. Accurus Biosciences Business Overview Table 32. Accurus Biosciences Antibody Humanization Product Table 33. Accurus Biosciences Revenue in Antibody Humanization Business (2017-2022) & (US$ Million) Table 34. Accurus Biosciences Recent Development Table 35. IONTAS Company Details Table 36. IONTAS Business Overview Table 37. IONTAS Antibody Humanization Product Table 38. IONTAS Revenue in Antibody Humanization Business (2017-2022) & (US$ Million) Table 39. IONTAS Recent Development Table 40. Lonza Company Details Table 41. Lonza Business Overview Table 42. Lonza Antibody Humanization Product Table 43. Lonza Revenue in Antibody Humanization Business (2017-2022) & (US$ Million) Table 44. Lonza Recent Development Table 45. Oak BioSciences Company Details Table 46. Oak BioSciences Business Overview Table 47. Oak BioSciences Antibody Humanization Product Table 48. Oak BioSciences Revenue in Antibody Humanization Business (2017-2022) & (US$ Million) Table 49. Oak BioSciences Recent Development Table 50. Panorama Research Company Details Table 51. Panorama Research Business Overview Table 52. Panorama Research Antibody Humanization Product Table 53. Panorama Research Revenue in Antibody Humanization Business (2017-2022) & (US$ Million) Table 54. Panorama Research Recent Development Table 55. PX'Therapeutics Company Details Table 56. PX'Therapeutics Business Overview Table 57. PX'Therapeutics Antibody Humanization Product Table 58. PX'Therapeutics Revenue in Antibody Humanization Business (2017-2022) & (US$ Million) Table 59. PX'Therapeutics Recent Development Table 60. Yurogen Biosystems Company Details Table 61. Yurogen Biosystems Business Overview Table 62. Yurogen Biosystems Antibody Humanization Product Table 63. Yurogen Biosystems Revenue in Antibody Humanization Business (2017-2022) & (US$ Million) Table 64. Yurogen Biosystems Recent Development Table 65. Research Programs/Design for This Report Table 66. Key Data Information from Secondary Sources Table 67. Key Data Information from Primary Sources List of Figures Figure 1. Antibody Humanization Product Picture Figure 2. Global Antibody Humanization Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Antibody Humanization Market Size 2017-2028 (US$ Million) Figure 4. United States Antibody Humanization Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Antibody Humanization Market Size 2017-2028 (US$ Million) Figure 6. United States Antibody Humanization Market Share in Global 2017-2028 Figure 7. Antibody Humanization Report Years Considered Figure 8. Product Picture of Monoclonal Antibodies Figure 9. Product Picture of Bispecific Antibodies Figure 10. Product Picture of CDR Grafted Antibodies Figure 11. Global Antibody Humanization Market Share by Type in 2022 & 2028 Figure 12. Global Antibody Humanization Market Size by Type (2017-2028) & (US$ Million) Figure 13. Global Antibody Humanization Market Share by Type (2017-2028) Figure 14. United States Antibody Humanization Market Share by Type in 2022 & 2028 Figure 15. United States Antibody Humanization Market Size by Type (2017-2028) & (US$ Million) Figure 16. United States Antibody Humanization Market Share by Type (2017-2028) Figure 17. Product Picture of HIV Figure 18. Product Picture of SARS Figure 19. Product Picture of RSV Figure 20. Product Picture of Prion Figure 21. Global Antibody Humanization Market Share by Application in 2022 & 2028 Figure 22. Global Antibody Humanization Market Size by Application (2017-2028) & (US$ Million) Figure 23. Global Antibody Humanization Market Share by Application (2017-2028) Figure 24. United States Antibody Humanization Market Share by Application in 2022 & 2028 Figure 25. United States Antibody Humanization Market Size by Application (2017-2028) & (US$ Million) Figure 26. United States Antibody Humanization Market Share by Application (2017-2028) Figure 27. North America Antibody Humanization Market Size Growth Rate 2017-2028 (US$ Million) Figure 28. U.S. Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 29. Canada Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. Europe Antibody Humanization Market Size Growth Rate 2017-2028 (US$ Million) Figure 31. Germany Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. France Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. U.K. Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Italy Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Russia Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Asia-Pacific Antibody Humanization Market Size Growth Rate 2017-2028 (US$ Million) Figure 37. China Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. Japan Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. South Korea Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. India Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Australia Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Taiwan Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Indonesia Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Thailand Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Malaysia Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Philippines Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Latin America Antibody Humanization Market Size Growth Rate 2017-2028 (US$ Million) Figure 48. Mexico Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Brazil Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Argentina Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Middle East & Africa Antibody Humanization Market Size Growth Rate 2017-2028 (US$ Million) Figure 52. Turkey Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Saudi Arabia Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. U.A.E Antibody Humanization Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. Accurus Biosciences Revenue Growth Rate in Antibody Humanization Business (2017-2022) Figure 56. IONTAS Revenue Growth Rate in Antibody Humanization Business (2017-2022) Figure 57. Lonza Revenue Growth Rate in Antibody Humanization Business (2017-2022) Figure 58. Oak BioSciences Revenue Growth Rate in Antibody Humanization Business (2017-2022) Figure 59. Panorama Research Revenue Growth Rate in Antibody Humanization Business (2017-2022) Figure 60. PX'Therapeutics Revenue Growth Rate in Antibody Humanization Business (2017-2022) Figure 61. Yurogen Biosystems Revenue Growth Rate in Antibody Humanization Business (2017-2022) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed
Accurus Biosciences IONTAS Lonza Oak BioSciences Panorama Research PX'Therapeutics Yurogen Biosystems
B-Cell Maturation Antigen (BCMA) Targeted Therapies market is segmented by region (country), play ... Read More
Sustained Release Ocular Drug Delivery Systems market is segmented by region (country), players, ... Read More
Blood-Brain Barrier Transport Drugs market is segmented by region (country), players, by Type and ... Read More